| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 |
# |
Score |
Template |
Links and tools | %id | First |
MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ | Last |
1 | -106.000 | 4iaq_A mol:protein length:403 Chimera protein of human 5-hydroxytryptamine receptor 1B and E. Coli soluble cytochrome b562 |
ali model follow.. |
35 | 1 | ................GGTCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIWHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRIADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKL--EDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS. |
403 |
2 | -106.000 | 5v54_A mol:protein length:395 5-hydroxytryptamine receptor 1B,OB-1 fused 5-HT1b receptor,5-hydroxytryptamine receptor 1B |
ali model follow.. |
39 | 8 | ..............................ISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIWHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRIADLEDRWRTLEDNLRVIERAAN---AAEVREALTRMRAAAEDAQRATPPALEDRSPASPEMEDFRHGFDILVGQIDDALRLADEGRVAEAQAAAEELRTTRNAYIQKYLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS. |
395 |
3 | -105.000 | 5wiu_A mol:protein length:422 D(4) dopamine receptor, soluble cytochrome b562 chimera |
ali model follow.. |
25 | 3 | TTMGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGR--DPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDAANEGKVKEAQAAAEQLKTTRNAYIQKYLAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPA-CSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC... |
422 |
4 | -104.000 | 6g79_S mol:protein length:364 5-hydroxytryptamine receptor 1B |
ali model follow.. |
40 | 2 | ....................SAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIWHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSV--------------------------------------------TSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTSE |
359 |
5 | -104.000 | 5tud_A mol:protein length:457 5-hydroxytryptamine receptor 2B,Soluble cytochrome b562 chimera |
ali model follow.. |
24 | 10 | IFCLVFADYKDDDDGAPTESIPEEMKQIVEEQGNKLHWAALLILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFAMWPLPLVLCPAWLFLDVLFSTASIWHLCAISVDRYIAIKKPIQANQYNSRATAFIKITVVWLISIGIAIPVPIKGIETDVDNPNNVLTKERFGDFMLFGSLAAFFTPLAIMIVTYFLTIHALQKKAADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKL--EDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLQTISNEQRASKVLGIVFFLFLLMWCPFFITNITLVLCDSNQTTLQMLLEIFVWIGYVSSGVNPLVYTLFNKTFRDAFGRYITCNYRAT |
434 |
6 | -103.000 | 6bqg_A mol:protein length:452 5-hydroxytryptamine receptor 2C,Soluble cytochrome b562 |
ali model follow.. |
23 | 5 | IALSYIFCLVFADYKDDDDGAPTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQAADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKL--EDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKNQKLMEKLLNVFVWIGYVNSGINPLVYTLFNKIYRRAFSNYLRCNYKVE |
428 |
7 | -102.000 | 5dsg_A mol:protein length:422 Muscarinic acetylcholine receptor M4,Endolysin,Endolysin,Muscarinic acetylcholine receptor M4 |
ali model follow.. |
24 | 2 | ........................PSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTVYIIKGYWPLGAVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPARRTTKMAGLMIAAAWVLSFVLWAPAILFWQFVVGKRTQCFIQFLSNPAVTFGTAIAAFYLPVVIMTVLYIHISLASRSRVNIFEMLRIDEGGGSGGDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAAETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYQMAARERKVTRTIFAILLAFILTWTPYNVMVLVNTFCQSC--IPDTVWSIGYWLCYVNSTINPACYALCNATFKKTFRHLLLCQYRNI |
410 |
8 | -102.000 | 4u15_A mol:protein length:418 Muscarinic acetylcholine receptor M3,Lysozyme,Muscarinic acetylcholine receptor M3 |
ali model follow.. |
25 | 7 | ..............................HTIWQVVFIAFLTGFLALVTIIGNILVIVAFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLSIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKMNIFEMLRIDEGGGSGGDEAEKLFNQDVDARNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYLIKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSC--IPKTYWNLGYWLCYINSTVNPVCYALCNKTFRTTFKTLLLCQCDKR |
406 |
9 | -102.000 | 5wf5_A mol:protein length:504 Human A2a adenosine receptor T4L chimera |
ali model follow.. |
25 | 1 | MKTIALSYIFCLVFADYKDDDDAMGQPVGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAANIAVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNTGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYRSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
488 |
10 | -102.000 | 6cm4_A mol:protein length:430 D(2) dopamine receptor, endolysin chimera |
ali model follow.. |
29 | 2 | .....................................YYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASALNLCAISIDRYTAVAMPMLYNTRYSSKRVTVMISIVWVLSFTISCPLLFGLNN-----ADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYKLSQQKEKKATQMAAIVAGVFIICWLPFFITHILNIHCD--CNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC..... |
430 |
11 | -101.000 | 4eiy_A mol:protein length:447 Adenosine receptor A2a/Soluble cytochrome b562 chimera |
ali model follow.. |
24 | 1 | MKTII-----ALSYIFCLVFADYKDDDDGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKNEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
431 |
12 | -101.000 | 6MH8 Entity 1(prereleased) |
ali follow.. |
24 | 1 | MKTII-----ALSYIFCLVFADYKDDDDGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKNEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
431 |
13 | -99.500 | 5mzj_A mol:protein length:434 Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a |
ali model follow.. |
26 | 1 | ....................ADYKDDDDGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKNEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
416 |
14 | -96.100 | 5uen_A mol:protein length:416 Adenosine receptor A1,Soluble cytochrome b562,Adenosine receptor A1 |
ali model follow.. |
24 | 6 | ...............................ISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFH--TCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAAKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKNEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKELKIAKSLALILFLFALSWLPLHILNCITLFCPS-CHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQ |
409 |
15 | -96.100 | 3rze_A mol:protein length:452 Histamine H1 receptor, Lysozyme chimera |
ali model follow.. |
27 | 1 | ............................TTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAESLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNC--CNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRSGEN |
448 |
16 | -96.000 | 3pbl_A mol:protein length:481 D(3) dopamine receptor, Lysozyme chimera |
ali model follow.. |
26 | 4 | .DDDDGAPASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGVWNFSRICCDVFVTLDVMMCTASIWNLCAISIDRYTAVVMPVHYQHGTGQSSVALMITAVWVLAFAVSCPLLFGFN----TTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAERMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQT-CHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSCGRPLE |
477 |
17 | -95.400 | 3d4s_A mol:protein length:490 Beta-2 adrenergic receptor/T4-lysozyme chimera |
ali model follow.. |
26 | 7 | .DAMGQPGNGSAFLLAPNRSHAPDHDVTQQRDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIWTLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKSRWYNQTPNRAKRVITTFRTGTWDAYKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNL--IRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLCLRRSSL |
483 |
18 | -95.100 | 4daj_A mol:protein length:479 Muscarinic acetylcholine receptor M3, Lysozyme |
ali model follow.. |
25 | 7 | ..............................HTIWQVVFIAFLTGFLALVTIIGNILVIVAFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLSIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKMNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYLIKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSC--IPKTYWNLGYWLCYINSTVNPVCYALCNKTFRTTFKTLLLCQCDKR |
449 |
19 | -94.000 | 3uon_A mol:protein length:467 Human M2 muscarinic acetylcholine, receptor T4 lysozyme fusion protein |
ali model follow.. |
25 | 2 | ..............DDSTDSSDNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRINIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPC--IPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNI |
463 |
20 | -93.400 | 3p0g_A mol:protein length:501 Beta-2 adrenergic receptor, Lysozyme |
ali model follow.. |
25 | 7 | .DAMGQPGNGSAFLLAPNRSHAPDHDVTQQRDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNL--IRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLCLRRSSL |
483 |
21 | -93.100 | 4u14_A mol:protein length:460 Muscarinic acetylcholine receptor M3,Endolysin,Muscarinic acetylcholine receptor M3 |
ali model follow.. |
25 | 7 | ..............................HTIWQVVFIAFLTGFLALVTIIGNILVIVAFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLSIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKMNCFEMLRIDEGLRLKIYKDCEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKTNSLRMLQQKRWDEAAVNLAKSRWYNQCPNRAKRVITTFRTGTWDAYLIKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSC--IPKTYWNLGYWLCYINSTVNPVCYALCNKTFRTTFKTLLLCQCDKR |
449 |
22 | -92.800 | 3v2w_A mol:protein length:520 Sphingosine 1-phosphate receptor 1, Lysozyme chimera |
ali model follow.. |
19 | 32 | ....SSVSDYVNYDIIVRHYNYTGKLNISADKENSIKLTSVVFILICCFIILENIFVLLTIWKTKKFHRPMYYFIGNLALSDLLAGVAYTANLLLSGA-TTYKLTPAQWFLREGSMFVALSASVFSLLAIAIERYITMLKMKLHNGSNN-FRLFLLISACWVISLILGGLPIMGWNCISALSSCSTV-LPLYHKHYILFCTTVFTLLLLSIVILYCRIYSLVRTRNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDETNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYASRSSENVALLKTVIIVLSVFIACWAPLFILLLLDVGCKVKTCDILFRAEYFLVLAVLNSGTNPIIYTLTNKEMRRAFIRIMGRPLEVL |
498 |
23 | -92.000 | 5cxv_A mol:protein length:515 Muscarinic acetylcholine receptor M1,Endolysin,Muscarinic acetylcholine receptor M1 |
ali model follow.. |
23 | 15 | FADYKDDDDAAAQTSAPPAVSPQITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASQASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDC--VPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKR |
489 |
24 | -91.500 | 4mqs_A mol:protein length:351 Muscarinic acetylcholine receptor M2 |
ali model follow.. |
30 | 6 | .DENLYFQGLEMDDSTDSSDNSLALTSPYLEKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVAN-----------------------------------------------------------------------------------------QDPVSTRKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPC--IPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNI |
339 |
25 | -90.800 | 5gli_A mol:protein length:464 Endothelin Receptor Subtype-B |
ali model follow.. |
17 | 4 | LAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLYIIYKNKCMRNGPNILIASLALGDLLHIVIAIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDVQKTAFMQFYATAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKNIFEMLRIDEGGGSGGDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYLNDHLKQRREVAKTVFCLVLVFALCWLPLHLARILKLTLYELLSFLLVLDYIGINMASLNSCANPIALYLVSKRFKNAFKSALCCWAQSP |
456 |
26 | -90.700 | 3kj6_A mol:protein length:366 Beta-2 adrenergic receptor |
ali model follow.. |
29 | 2 | ...FGQPGNGSAFLLAPNRSHAPDHDVTQQRDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGR----------------------------------------------------------------------------TGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNL--IRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLCLRRSSL |
348 |
27 | -90.100 | 4z34_A mol:protein length:464 Lysophosphatidic acid receptor 1, Soluble cytochrome b562 |
ali model follow.. |
15 | 33 | .QFTAMNEPQCFYNESIAFFYNRSGKHLATEWNTVSKLVMGLGITVCIFIMLANLLVMVAIYVNRRFHFPIYYLMANLAAADFFAGLAYFYLMFNTGPNT-RRLTVSTWLLRQGLIDTSLTASVANLLAIAIERHITVFRMQLHTR-MSNRRVVVVIVVIWTMAIVMGAIPSVGWNCICDIENCSNMAPLYSDSYLVFWAI-FNLVTFVVMVVLYAHIFGYVADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLE------DKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLRNRDTMMSLLKTVVIVLGAFIICWTPGLVLLLLDVCCPQC--DVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSATFRQILGRPLEVL |
442 |
28 | -89.700 | 4z36_A mol:protein length:459 Lysophosphatidic acid receptor 1,Soluble cytochrome b562 |
ali model follow.. |
16 | 33 | .QFTAMNEPQCFYNESIAFFYNRSGKHLATEWNTVSKLVMGLGITVCIFIMLANLLVMVAIYVNRRFHFPIYYLMANLAAADFFAGLAYFYLMFNTGPNT-RRLTVSTWLLRQGLIDTSLTASVANLLAIAIERHITVFRMQLHTR-MSNRRVVVVIVVIWTMAIVMGAIPSVGWNCICDIENCSNMAPLYS-CSYLVFWAIFNLVTFVVMVVLYAHIFGYVADLEDNWETLNDNLKVIEKADNAAQV-----------KDALTKMRAAALDAQKGGSGGSDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLRNRDTMMSLLKTVVIVLGAFIICWTPGLVLLLLDCCCPQC--DVLAYEKFFLLLAEFNSAMNPIIYSYRDKEMSATFRQILGRPLEVL |
437 |
29 | -89.700 | 2y00_A mol:protein length:315 BETA-1 ADRENERGIC RECEPTOR |
ali model follow.. |
38 | 7 | ...............................SQQWEAGMSLLMALVVLLIVAGNVLVIAAIGSTQRLQTLTNLFITSLACADLVVGLLVVPFGATLVVRGTWLWGSFLCELWTSLDVLCVTASIETLCVIAIDRYLAITSPFRYQSLMTRARAKVIICTVWAISALVSFLPIMMHWWRDEDPQALKCDFVTNRAYAIASSIISFYIPLLIMIFVALRVYREAKEQIRKID-----------------------------------------------------------------------------------------------RASKRKTSRVMLMREHKALKTLGIIMGVFTLCWLPFFLVNIVNVFNRDL--VPDWLFVAFNWLGYANSAMNPIIYC-RSPDFRKAFKRLLAFPRKAD |
306 |
30 | -87.800 | 4gbr_A mol:protein length:309 Beta-2 adrenergic receptor |
ali model follow.. |
35 | 1 | ...............................DEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKI--------------------------------------------------------------------------------------------------------DKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNL--IRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLCLRRSSL |
291 |
31 | -87.200 | 5g53_A mol:protein length:314 ADENOSINE RECEPTOR A2A |
ali model follow.. |
31 | 2 | ...............................PIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMES----------------------------------------------------------------------------------------------QPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLEN |
310 |
32 | -87.100 | 5tgz_A mol:protein length:452 Cannabinoid receptor 1,Flavodoxin,Cannabinoid receptor 1 |
ali model follow.. |
20 | 1 | ..............GGGRGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCPSYHFIGSLAVADLLGSVIFVYSFIDFHVFH-RKDSRNVFLFKLGGVTASFTASVGSLFLAAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQS-VCSDIFPHIDKTYLMFWIGVVSVLLLFIVYAYMYILWKAHSHAVAKALIVYGSTTGNTEYTAETIARELADAGYEVDSRDAASVEAGGLFEGFDLVLLGCSTWGDDSIELQDDFIPLFDSLEETGAQGRKDPRAARDDIVGWAHDVRGAIPDQARMDIELAKTLVLILVVLIICWGPLLAIMVYDVFG-KMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFP...... |
441 |
33 | -86.800 | 5glh_A mol:protein length:498 Endothelin Receptor Subtype-B |
ali model follow.. |
16 | 7 | ...AEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLYIIYKNKCMRNGPNILIASLALGDLLHIVIAIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGRICLLFYATAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDENSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYLNDHLKQRREVAKTVFCLVLVFALCWLPLHLARILKLTLYELLSFLLVLDYIGINMASLNSCANPIALYLVSKRFKNAFKSALCCWAQS. |
498 |
34 | -86.600 | 3vg9_A mol:protein length:326 Adenosine receptor A2a |
ali model follow.. |
31 | 2 | ...............................PIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKQHDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMES----------------------------------------------------------------------------------------------QPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
310 |
35 | -86.200 | 3pwh_A mol:protein length:329 Adenosine receptor A2a |
ali model follow.. |
31 | 2 | ...............................PIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLKQMES----------------------------------------------------------------------------------------------QPLPGERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
310 |
36 | -85.700 | 2ydo_A mol:protein length:325 ADENOSINE RECEPTOR A2A |
ali model follow.. |
31 | 2 | ...............................PIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSAAAADILVGVLAIPFAIA--ISTGFCAACHGCLFIACFVLVLTASSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMES----------------------------------------------------------------------------------------------QPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
310 |
37 | -85.100 | 3sn6_R mol:protein length:514 Endolysin,Beta-2 adrenergic receptor |
ali model follow.. |
29 | 147 | LAKSRWYNQTPNRAKRVITTFRTGTWDAYAADEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGR----------------------------------------------------------------------------TGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNL--IRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLCLRRSSL |
496 |
38 | -81.500 | 6d9h_R mol:protein length:389 Chimera protein of Muscarinic acetylcholine receptor M4 and Adenosine receptor A1 |
ali model follow.. |
27 | 29 | FTPVNGSSGNQSVRLVTSSSLEVLFQGPPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFH--TCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAAKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKV------------------------------------------------------------------------------------------------SASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPS-CHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQ |
365 |
39 | -80.500 | 5n2s_A mol:protein length:436 Soluble cytochrome b562,Adenosine receptor A1 |
ali model follow.. |
26 | 82 | .NEGKVKEAQAAAEQLKTTRNAYIQKYLASSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVLVGALVIPLAILINIGPQTYFH--TCLMVACPVLILAQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAAKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFALIRKQLNKKV------------------------------------------------------------------------------------------------SASSGDPQKYYGKELKIAKSAALIAFLFALSWLPLHILNCITLFCPS-CHKPSILTYIAIFLAHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRSQ |
417 |
40 | -79.400 | 5t04_A mol:protein length:513 Neurotensin receptor type 1,Endolysin,Neurotensin receptor type 1 |
ali model follow.. |
18 | 1 | ....DYKDDDDATSTSESDTAGPNSDLDVNTDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLVHYHLGSLALSDLLILLLAMPVELYNFIWVHWAFGDAGCRGYYFLRDACTYATALNVASLSVERYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSPGGLVCTPIVDKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNYNQTPNRAKRVITTFRTGTWDAYGSGSPGRVQALRHGVLVLRAVVIAFVVCWLPYHVRRLMFCYISDE-DFYHYFYMLTNALAYASSAINPILYNLVSANFRQVFLSTLACLCPGW |
495 |
41 | -79.100 | 5jqh_A mol:protein length:471 Endolysin,Beta-2 adrenergic receptor |
ali model follow.. |
31 | 147 | LAKSRWYNQTPNRAKRVITTFRTGTWDAYAADEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKI------------------------------------------------------------------------------------------------------DIDKFALKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNL--IRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLCLRRSSL |
470 |
42 | -78.000 | 5zbh_A mol:protein length:527 Neuropeptide Y receptor type 1,T4 Lysozyme,Neuropeptide Y receptor type 1 |
ali model follow.. |
16 | 18 | ....VENHSVHSNFSEKNAQLLAFENDDCHLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIWSLVLIAVERHQLIINPRGWR--PNNRHAYVGIAVIWVLAVASSLPFLIYQVMTDEPFQNVTLDASHRLSYTTLLLVLQYFGPLCFIFICYFKIYIRLKRRNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYDNKYRSSETKRINIMLLSIVVAFAVCWLPLTIFNTVFDWNHQATCNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRS |
503 |
43 | -77.700 | 4ntj_A mol:protein length:466 P2Y purinoceptor 12,Soluble cytochrome b562,P2Y purinoceptor 12 |
ali model follow.. |
17 | 2 | ...YKDDDDGAPQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQ-IRSKSNFIIFLKNTVISDLLM-ILTFPFKILSDAKLTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFIVNYICQVIFWINFLIVIVCYTLITKELYRSYVRTADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAAEQLKTTRNAYIQKYLRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTAENTLFYVKESTLWLTSLNACLNPFIYFFLCKSFRNSLISMLKCPNSAT |
435 |
44 | -77.500 | 5wqc_A mol:protein length:560 Orexin receptor type 2,GlgA glycogen synthase,Orexin receptor type 2 |
ali model follow.. |
21 | 27 | .ELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFK--STAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLTVCD-IYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQGIDCSFWNESYLTGSRDERKKSLLSKFGMDSYFEPFGLVALEAMCLGAIPIASAVGGLRDIITNETGILVKAGDPGELANAILKALELSRSDLSKFRENCKKRAMSFSKQIRARRKTARMLMVVLLVFAICYLPISILNVLKRVFGEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCL.. |
548 |
45 | -77.400 | 5nj6_A mol:protein length:437 Proteinase-activated receptor 2,Soluble cytochrome b562,Proteinase-activated receptor 2 |
ali model follow.. |
14 | 2 | ...............VETVFSVDEFSASVLTGKLTTVFLPIVYTIVFVVALPSNGMALWVFLFRTKKKAPAVIYMANLALADLLS-VIWFPLKIAYHIHGNWIYGEALCNVLIGFFYANMYCSILFLTCLSVQRAWEIVNPMGH-SRKKANIAIGISLAIWLLILLVTIPLYVVKQTIFPALQITTCHDVDMFNYFLSLAIGVFLFPAFLTASAYVLMIRALADLEDNWETLNDNLKVIEKADNAAQV-----KDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLENSEKKRKRAIKLAVTVAAMYLICFTPSNLLLVVHYFLIKSQGQSHVLYIVALCLSTLNSCIDPFVYYFVSHDFRDHAKNALLCRSVRT |
413 |
46 | -75.800 | 4xee_A mol:protein length:541 Neurotensin receptor type 1, Endolysin chimera |
ali model follow.. |
18 | 1 | ....DYKDDDDATSTSESDTAGPNSDLDVNTDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIHHPWAFGDAGCRGYYFLRDACTYATALNVASLSVERYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGTHPGGATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVHQAAE-------------------------------------------------------------------------------QGRVCTVGTHNGLEHSTFNMTIEPGRVQALRHGVLVLRAVVIAFVVCWLPYHVRRLMFCYISDEFDFYHYFYMLTNALFYASSAINPILYNLVSANFRQVFLSTLACLCPGW |
359 |
47 | -75.700 | 2z73_A mol:protein length:448 Rhodopsin |
ali model follow.. |
20 | 1 | ..MGRDLRDNETWWYNPSIVVHPHWREFDQVPDAVYYSLGIFIGICGIIGCGGNGIVIYLFTKTKSLQTPANMFIINLAFSDFTFSLVGFPLMTISCFLKKWIFGFAACKVYGFIGGIFGFMSIMTMAMISIDRYNVIGRPMAASKKMSHRRAFIMIIFVWLWSVLWAIGPIFGWGAYTLEGVLCNCSFSTTRSNILCMFILGFFGPILIIFFCYFNIVMSVSNHEKEMAAMAKRLN-----------------------------------------------------------------------------------------AKELRKAQAGANAEMRLAKISIVIVSQFLLSWSPYAVVALLAQF-GPLEWVTPYAAQLPVMFAKASAIHNPMIYSVSHPKFREAISQTFPW..... |
332 |
48 | -75.500 | 1gzm_A mol:protein length:349 RHODOPSIN |
ali model follow.. |
18 | 2 | MNGTEGPNFYVPFSNKTGVVRSPFEAQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFR-FGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGITNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAA-----------------------------------------------------------------------------------------------------QQQESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGS-DFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGKNPL |
329 |
49 | -75.500 | 4ej4_A mol:protein length:461 Delta-type opioid receptor, Lysozyme chimera |
ali model follow.. |
19 | 14 | ...................................AIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALA-TSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMV-MAVTQPRDGAVVCSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRNIFEMLRIDEGLRLKQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQ |
459 |
50 | -75.300 | 6gdg_A mol:protein length:479 TrxA,Adenosine receptor A2a |
ali model follow.. |
29 | 124 | LLLFANGEVAATKVGALSKGQLKEFLDANLAEAAAKAVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAIT--ISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMES----------------------------------------------------------------------------------------------QPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQ |
463 |
51 | -75.200 | 4dkl_A mol:protein length:464 Mu-type opioid receptor, lysozyme chimera |
ali model follow.. |
18 | 1 | ...................GSHSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALA-TSTLPFQSVNYLMGTWPFGNILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMF-MATTKYRQGSIDCTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRNIFEMLRIDEGLRLKIYKNTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINRTGTWDAYEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTI |
461 |
52 | -75.100 | 4zj8_A mol:protein length:553 human OX1R fusion protein to P.abysii glycogen synthase |
ali model follow.. |
19 | 19 | MGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFK--STARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELSVCD-LYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQGIDCSFWNESYLTGSRDERKKSLLSKFGMDEGSREFVRELYGSVDFVIIPSYFEPFGLVALEAMCLGAIPIASAVGGLRDIITNETGLSRSDLSKFRENCKKRAMSFSKQMRARRKTAKMLMVVLLVFALCYLPISVLNILKRVFGMFRQASDACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPG. |
542 |
53 | -75.000 | 3zev_A mol:protein length:338 NEUROTENSIN RECEPTOR 1 TM86V |
ali model follow.. |
19 | 1 | .................GPGSGPNSDLDVNTDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKQSLQSTVDYYLGSLALSDLLILLLAMPVELYNFIWVHWAFGDAGCRGYYFLRDACTYATALNVVSLSVELYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNLSGDGTHPDTATLKVVIQVNTFMSFLFPMLVASILNTVIANKLTVMVHQAA-----------------------------------------------------------------------------------------------EQGRVCTEPGRVQALRRGVLVLRAVVIAFVVCWLPYHVRRLMFCYISDEFDFYHYFYMLTNALVYVSAAINPILYNLVSANFRQVFLSTLACLCPGT |
330 |
54 | -74.900 | 4bv0_A mol:protein length:338 NEUROTENSIN RECEPTOR TYPE 1 |
ali model follow.. |
19 | 1 | .................GPGSGPNSDLDVNTDIYSKVLVTAIYLALFVVGTVGNGVTLFTLARKQSLQSRVDYYLGSLALSDLLILLFALPVDVYNFIWHPWAFGDAGCKGYYFLREACTYATALNVVSLSVELYLAIRHPFKHKTLMSRSRTKKFISAIWLASALLAIPMLFTVGLQNLSGDGTHPGGATLKVVIQLNTFMSFLFPMLVASILNTVIARRLTVMVHQAA-----------------------------------------------------------------------------------------------EQGRVCTEPGRVQALRRGVLVLRAMVIAFVVCWLPYHVRRLMFVYISDEFDFYHYFYMLSNALVYVSAAINPILYNLVSANFRQVFLSTLACLCPGT |
330 |
55 | -74.600 | 4buo_A mol:protein length:335 NEUROTENSIN RECEPTOR TYPE 1 |
ali model follow.. |
19 | 2 | ...................GSGPNSDLDVNTDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKQSLQSTVDYYLGSLALSDLLILLLAMPVELYNFIWVHWAFGDAGCRGYYFLRDACTYATALNVVSLSVELYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNLSGDGTHPGGATLKVVIQVNTFMSFLFPMLVASILNTVIANKLTVMVHQ-------------------------------------------------------------------------------------------------AAFNMTIEPGRVQALRRGVLVLRAVVIAFVVCWLPYHVRRLMFCYISDE-DFYHYFYMLTNALVYVSAAINPILYNLVSANFRQVFLSTLACLCPGT |
327 |
56 | -74.400 | 4bwb_A mol:protein length:338 NEUROTENSIN RECEPTOR TYPE 1 |
ali model follow.. |
19 | 1 | .................GPGSGPNSDLDVNTDIYSKVLVTAIYLALFVVGTVGNGVTLFTLARKKSLQSRVDYYLGSLALSDLLILLFALPVDLYNFIWHPWAFGDAGCKGYYFLREACTYATALNVVSLSVELYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNLSGDGTHPGGATLRVVIQLNTFMSFLFPMLVASILNTVAARRLTVMVHQ-----------------------------------------------------------------------------------------------AAEQGRVCTEPGRVQALRRGVLVLRAVVIAFVVCWLPYHVRRLMFVYISDE-DFYHYFYMLSNALVYVSAAINPILYNLVSANFRQVFLSTLACLCPGT |
330 |
57 | -74.100 | 2ks9_A mol:protein length:364 Substance-P receptor |
ali model follow.. |
20 | 2 | .....DNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQ--PRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEI--------------------------------------------------------------------------------------------------PGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFIS |
327 |
58 | -73.900 | 5xjm_A mol:protein length:422 Type-2 angiotensin II receptor,Soluble cytochrome b562,Type-2 angiotensin II receptor |
ali model follow.. |
18 | 10 | ..................................HLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLL-LATLPLWATYYSYRDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQR-RNPWQASYIVPLVWCMACLSSLPTFYFRDVRTEYLGVNACIMAWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNADLEDNWETLN--DNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWL |
410 |
59 | -73.600 | 4djh_A mol:protein length:480 Kappa-type opioid receptor, Lysozyme |
ali model follow.. |
18 | 1 | ..............GGTTMGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALV-TTTMPFQSTVYLMNSWPFGDVLCKIVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVEDVDVIECSLQWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGNIFEMLRIDEGLRDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRM |
474 |
60 | -73.200 | 6GPX Entity 1(prereleased) |
ali follow.. |
19 | 1 | ......................GAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINYKKLKCLTDIYLLNLAISDLLF-LITLPLWAHS-AANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPNIIFTKCQKEDSVYVCGPYGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRMKKYTCTVCGYIYNPEDGDPDNGVN----------------------------------------------------------PGTDFKDIPDDWVCPLCGVGKDQFEEVEEEKKRHRDVRVIFTIMIVYFLFWTPYNIVILLNTFQEESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGEVLFQ. |
349 |
61 | -72.800 | 5zbq_A mol:protein length:525 Neuropeptide Y receptor type 1,T4 Lysozyme |
ali model follow.. |
19 | 4 | LFSQVENHSVHSNFSEKNAQLLAFENDDCHLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIWSLVLIAVERHQLIINPRGWR--PNNRHAYVGIAVIWVLAVASSLPFLIYQVMTDEPFQNVTLDASHRLSYTTLLLVLQYFGPLCFIFICYFKIYIRLKRRNNM--------------------------------------------------------------------------------------------------MDKMRDNKYRSSETKRINIMLLSIVVAFAVCWLPLTIFNTVFDWNHQATCNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRS |
341 |
62 | -72.300 | 4mbs_A mol:protein length:414 Chimera protein of C-C chemokine receptor type 5 and Rubredoxin |
ali model follow.. |
16 | 1 | ....GAPDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINYKRLKSMTDIYLLNLAISDLFF-LLTVPFWAHY-AAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPNIIFTRSQKEGLHYTCSSHFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRMKKYTCTVCGYIYNPEDGDPDNGVN----------------------------------------------------------PGTDFKDIPDDWVCPLCGVGKDQFEEVEEEKKRHRDVRLIFTIMIVYFLFWAPYNIVLLLNTFQESSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEEFRNYLLVFFQKHIAKR |
372 |
63 | -72.100 | 6GPS Entity 1(prereleased) |
ali follow.. |
18 | 7 | .RFIRNTQESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINYKKLKCLTDIYLLNLAISDLLF-LITLPLWAHS-AANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPNIIFTKCQKEDSVYVCGPYGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRMKKYTCTVCGYIYNPEDGDPDNGVN----------------------------------------------------------PGTDFKDIPDDWVCPLCGVGKDQFEEVEEEKKRHRDVRVIFTIMIVYFLFWTPYNIVILLNTFQEESTSQLDQATQVTETLGMTHCCINPIIYAFVGEEFRSLFHIALGCRIAPL |
377 |
64 | -71.600 | 5ndd_A mol:protein length:619 Lysozyme,Proteinase-activated receptor 2,Soluble cytochrome b562,Proteinase-activated receptor 2 |
ali model follow.. |
15 | 203 | ..................................TTVFLPIVYTIVFVVALPSNGMALWVFLFRTKKKAPAVIYMANLALADLLS-VIWFPLKIAYHIHGNWIYGEALCNVLIGFFYANMYCSILFLTCLSVQRAWEIVNPMGHSR-KKANIAIGISLAIWLLILLVTIPLYVVKQTIFPALQITTCHDVDMFNYFLSLAIGVFLFPAFLTASAYVLMIRALADLEDNWETLNDNLKVIEKADNAAQV-----KDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLENSEKKRKRAIKLAVTVAAMYLICFTPSNLLLVVHYFLIKSQGQSHVLYIVALCLSTLNSCIDPFVYYFVSHDFRDHAKNALLCRSVRT |
595 |
65 | -71.500 | 4xnv_A mol:protein length:421 P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1 |
ali model follow.. |
16 | 18 | ...AGPGSSWGNSTVASTAAVSSSFKCALTKTGFQFYYLPAVYILVFIIGFLGNSVAIWMFVFHMKPWSGISVYMFNLALADFLY-VLTLPALIFYYFNKDWIFGDAMCKLQRFIFHVNLYGSILFLTCISAHRYSGVVYPLKSLGRLKKKNAICISVLVWLIVVVAISPILFYSGTGVRKNKTITCYLRSYFIYSMCTTVAMFCVPLVLILGCYGLIVRALIYKMKKYTCTVCGYIYNPEDGDPDNG----------------------------------------------------------VNPGTDFKDIPDDWVCPLCGVGKDQFEEVEEPLRRKSIYLVIIVLTVFAVSYIPFHVMKTMNLRARAFNDRVYATYQVTRGLASLNSCVNPILYFLAGDTFRRRLSRATRKASRRS |
394 |
66 | -70.900 | 5vbl_B mol:protein length:407 Apelin receptor,Rubredoxin,Apelin receptor Chimera |
ali model follow.. |
17 | 11 | FCLVFADYKDDDDKFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRSREKRRSADIFIASLAVADLTFVVTLPLWATYTYRDYDWPFGTFFCKLSSYLIFVNMYASAFCLTGLSFDRYLAIVRPVANARLRLRVSGAVATAVLWVLAALLAMPVMVLRTTGDENTNKVQCEWAWEVGLGVSSTTVGFVVPFTIMLTCYFFIAQTIAMKKYTCTVCGYIYNPEDGDPDNGVN--------------------------------------------------------------PGTDFKDIPDDWVCPLCGVGKDQFEEVEERRRLLSIIVVLVVTFALCKMPYHLVKTLYMLGSDFDLFLMNIFPYCTCISYVNSCLNPFLYAFFDPRFRQACTSMLLMGQSRL |
390 |
67 | -70.300 | 6cmo_R mol:protein length:463 chimera protein of Soluble cytochrome b562 and Rhodopsin |
ali model follow.. |
19 | 163 | ...............................EPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVLGGFTSTLYTSLHGYFVFGPTGCNLQGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFR-FGENHAIMGVAFTWVMALACAAPPLAGWSRYIPEGLQCSCGIVNNESFVIYMFVVHFTIPMIIIFFCYGQLVFTVKEAAA-----------------------------------------------------------------------------------------------------QQQESATTQKAEKEVTRMVIIYVIAFLICWVPYASVAFYIFTHQGS-CFGPIFMTIPAFFAKSAAIYNPVIYIMMNKQFRNCMLTTICC..... |
453 |
68 | -68.700 | 6d26_A mol:protein length:470 Prostaglandin D2 receptor 2, Endolysin chimera |
ali model follow.. |
15 | 3 | .....SANATLKPLCPILEQMSRLQSHSATSIRYIDHAAVLLHGLASLLGLVENGVILFVVGC-RMRQTVVTTWVLHLALSDLLA-SASLPFFTYFLAVGSWELGTTFCKLHSSIFFLNMFASGFLLSAISLDRCLQVVRPVWAQNHRTVAAAHKVCLVLWALAVLNTVPYFVFRDTISRLDGRIMCYYNVLAALAVSKFLLAFLVPLAIIASSHAAVSLRLQHRADLGLQHRNIFEMLRIDEGGGSGGDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSTTFRTGTWDAYRRRPGRFVRLVAAVVAAFALCWGPYHVFSLLEARAHANPGLRPLVLPFVTSLAFFNSVANPVLYVLTCPDMLRKLRRSLRTVLESV |
451 |
69 | -68.100 | 6dde_R mol:protein length:356 Mu-type opioid receptor |
ali model follow.. |
21 | 31 | QSDPCGPNRTGLGENLYFQGSHSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALA-TSTLPFQSVNYLMGTWPFGNILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSNLLKICVFIFAFIMPVLIITVCYGLMILRLKSV------------------------------------------------------------------------------------------------------RMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSST. |
355 |
70 | -67.900 | 5zkq_A mol:protein length:438 Platelet-activating factor receptor,Endolysin,Endolysin,Platelet-activating factor receptor |
ali model follow.. |
13 | 1 | ...................GAPEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKNEIKIFMVNLTMADMLF-LITLPLWIVYYQNQNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRYQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGDVTRPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVNIFEMLRIDEGGGSGGDDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYAEVKRRDLWMACTVLAVFIICFVPHHVVQLPWTLAEKFHQAINDAHQVTLCLLSTNCVLNPVIYCFLTKKFRKHLTEKFYSMRSSR |
429 |
71 | -67.000 | 5x33_A mol:protein length:523 LTB4 receptor,Lysozyme,LTB4 receptor |
ali model follow.. |
17 | 4 | ....................DYKDDDDKEFSNTFIPLLAMILLSVSMVVGLPGNTFVVWSILKRMRKRSVTALMVLNLALADLAV-LLTAPFFLHFLTWGTWSFGLAGCRLCHYICGVSMYASVLLITAMSLDRSLAVASPFLSQKVRTKTAARWLLVGIWGASFLLATPVLAFRKVVKLTNETDLCLAVHKAFHLLFEAFTGFVVPFLIVVASYADISRRLRARGSGSNIFEMLRINQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGSGSRFHRRRRTGRLVVIIILAFAAFWLPYHVVDLVEGSRVQSKQQLRNARKVCIALAFLSSSVNPLLYACAGGGLLRSAGVGFVAKLLEA |
473 |
72 | -66.700 | 6CSY Entity 1(prereleased) |
ali follow.. |
26 | 133 | LAKSRWYNQTPNRAKRVITTFRTGTWDAYAADEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKFXLRRSSLKAYGNGYSSNGNTGEQSG..................................................................................................................................................................... |
396 |
73 | -64.600 | 2lnl_A mol:protein length:309 C-X-C chemokine receptor type 1 |
ali model follow.. |
21 | 2 | .................PPADEDYSPCMLETETLNKYVVIIAYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLF-ALTLPIWAASKVNG-WIFGTFLCKVVSLLKEVNFYSGILLLACISVDRYLAIVHATRTLTQKR-HLVKFVCLGCWGLSMNLSLPFFLFRQAYHPNNSSPVCTAKWRMVLRILPHTFGFIVPLFVMLFCYGFTLRTLFKAHM--------------------------------------------------------------------------------------------------------------GQKHRAMRVIFAVVLIFLLCWLPYNLVLLADTLMRTQVIQESRALDATEILGFLHSCLNPIIYAFIGQNFRHGFLKILAMHGLVS |
308 |
74 | -64.500 | 5o9h_A mol:protein length:317 C5a anaphylatoxin chemotactic receptor 1 |
ali model follow.. |
23 | 8 | ...................................DILALVIFAVVFLVGVLGNALVVW-VTAFEAKRTINAIWFLNLAVADFLA-CLALPALFTSIVQHHWPFGGAACSILPSLILLNMYASILLLATISADRFLLVFKPAWCQRFRGAGLAWILCAVAWGLALLLTIPSALYRVVREEYFPPKVLCGVDERAVAIVRLVLGFLWPLLTLTICYTFILLRTWSARE--------------------------------------------------------------------------------------------------------------TRSTKTLKVVVAVVASFFIFWLPYQVTGIMMSFLEPSSPTFLLLDSLCVSFAYINCCINPIIYVVAGQGFQGRERKSLPELLREV |
293 |
75 | -64.200 | 5xsz_A mol:protein length:477 Lysophosphatidic acid receptor 6a,Endolysin,Lysophosphatidic acid receptor 6a |
ali model follow.. |
16 | 3 | ..........YNTSLEMEMLNVSNVTHCPKNDNFKYPLYSMVFSIVFMVGLITNVAAMYIFMCSLKLRNETTTYMMNLVVSDLLF-VLTLPLRVFYFVQQNWPFGSLLCKLSVSLFYTNMYGSILFLTCISVDRFLAIVYPFRSRGLRTKRNAKIVCAAVWVLVLSGSLPTGFMLNSTNLENNSISCFENFSSKVVIFIETVGFLIPLMLNVVCSAMVLQTLRRPNTVNIFEMLRIDNGLRLKNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYLNKKKILRMIIVHLFIFCFCFIPYNVNLVFYSLVRKGCAAESVVYPIALCIAVSNCCFDPIVYYFTSETIQNSASSEDLYF.... |
476 |